Ekso Bionics
EKSO
#10308
Rank
A$17.03 M
Marketcap
A$6.49
Share price
5.41%
Change (1 day)
-58.24%
Change (1 year)

Operating Margin for Ekso Bionics (EKSO)

Operating Margin as of December 2025 (TTM): -70.74%

According to Ekso Bionics 's latest financial reports and stock price the company's current Operating Margin is -70.74%. At the end of 2024 the company had an Operating Margin of -63.21%.

Operating Margin history for Ekso Bionics from 2014 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-63.21%-23.98%
2023-83.14%-28.81%
2022-116.79%34.52%
2021-86.82%-51.27%
2020-178.17%104.38%
2019-87.17%-63.4%
2018-238.19%-39.86%
2017-396.06%139.98%
2016-165.04%-27.03%
2015-226.19%-64.32%
2014-633.92%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
AtriCure
ATRC
-9.38%-86.74%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
-44.27%-37.42%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
-2.88%-95.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biolase
BIOL
-58.86%-16.79%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.